AP

J&J suspends COVID-19 vaccine sales forecast

Apr 19, 2022, 4:40 AM | Updated: 10:47 pm

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

A global supply surplus and uncertainty about future demand — fueled in part by vaccine hesitancy in some developing markets — prompted the change, J&J said Tuesday. The company also reported a better-than-expected first-quarter profit and announced a dividend increase.

J&J’s one-shot vaccine brought in $457 million in global sales during the first quarter, while the company’s pharmaceutical sales as a whole totaled nearly $13 billion.

The vaccine registered only $75 million in sales in the U.S., or about 25% less than what it rang up after debuting in last year’s first quarter.

J&J has said it doesn’t intend to profit from the vaccine. But it said in January that the shot could bring in between $3 billion and $3.5 billion in sales this year, as countries continue to fight variants of the virus.

Demand for initial vaccine doses and booster shots has slowed since shots from J&J, Pfizer and Moderna entered the U.S. market last year. More than 82% of the U.S. population age 5 and older has already received at least one vaccination dose, according to the Centers for Disease Control and Prevention.

Options from Pfizer and Moderna also have been much more commonly used in the United States.

U.S. regulators also have said that most Americans should receive the Pfizer or Moderna shots instead of J&J’s version due to a rare blood clotting problem tied to the shot.

Vaccine sales are a small part of the total revenue picture for Johnson & Johnson. The company also sells medical devices, consumer health products like Band-Aids and a range of pharmaceuticals. That includes the cancer treatment Darzalex, which brought in $1.86 billion in the quarter.

Overall, J&J’s profit fell 17% to $5.15 billion in the first quarter, as research and development costs and other expenses climbed. Adjusted earnings came to $2.67 per share, as total revenue grew 5% to $23.4 billion.

Analysts expected, on average, earnings of $2.58 per share on $23.62 billion in revenue.

J&J said Tuesday that it now expects 2022 adjusted earnings of $10.15 to $10.35 per share, a drop from its previous forecast that company officials attributed to foreign currency rate changes.

Wall Street expects, on average, earnings of $10.55 per share.

Separately, the company said Tuesday that it was raising the quarterly dividend it pays shareholders by 7 cents to $1.13 per share. That will hike the annual payout to $4.52 per share from $4.24.

Shares of New Brunswick, New Jersey-based Johnson & Johnson, which is a component of the Dow Jones Industrial Average, climbed 3% to $183.03 in late-morning trading.

The Dow was up around 1%.

___

Follow Tom Murphy on Twitter: https://twitter.com/thpmurphy

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

Republican presidential candidates, former New Jersey Gov. Chris Christie, left, talking with forme...

Associated Press

The GOP debate field was asked about Trump. But most of the stage’s attacks focused on Nikki Haley

The four Republican presidential candidates debating Wednesday night mostly targeted each other instead of Donald Trump.

2 days ago

Law enforcement officers head into the University of Nevada, Las Vegas, campus after reports of an ...

Associated Press

Police say 3 dead, fourth wounded and shooter also dead in University of Nevada, Las Vegas attack

Police said a suspect was found dead Wednesday as officers responded to an active shooter and reports of multiple victims at UNLV.

2 days ago

President Joe Biden's son, Hunter Biden, leaves after a court appearance, July 26, 2023, in Wilming...

Associated Press

Republicans threaten contempt proceedings if Hunter Biden refuses to appear for deposition

House Republicans are threatening to hold Hunter Biden in contempt if he does not show up this month for a closed-door deposition.

2 days ago

Sen. Tommy Tuberville, R-Ala., listens to a question during a news conference, March 30, 2022, in W...

Associated Press

Tuberville is ending blockade of most military nominees, clearing way for hundreds to be approved

Sen. Tommy Tuberville announced Tuesday that he's ending his blockade of hundreds of military promotions, following heavy criticism.

3 days ago

An employee works inside the Hanwha Qcells Solar plant on Oct. 16, 2023, in Dalton, Ga. On Tuesday,...

Associated Press

US job openings fall to lowest level since March 2021 as labor market cools

U.S. employers posted 8.7 million job openings in October, the fewest since March 2021, in a sign that hiring is cooling.

3 days ago

Megyn Kelly poses at The Hollywood Reporter's 25th annual Women in Entertainment Breakfast, Dec. 7,...

Associated Press

The fourth GOP debate will be a key moment for the young NewsNation cable network

By airing the fourth Republican presidential debate, NewsNation network will almost certainly reach the largest audience in its history.

3 days ago

Sponsored Articles

Follow @KTAR923...

The best ways to honor our heroes on Veterans Day and give back to the community

Veterans Day is fast approaching and there's no better way to support our veterans than to donate to the Military Assistance Mission.

Follow @KTAR923...

West Hunsaker at Morris Hall supports Make-A-Wish Foundation in Arizona

KTAR's Community Spotlight this month focuses on Morris Hall and its commitment to supporting the Make-A-Wish Foundation in Arizona.

...

Desert Institute for Spine Care

Desert Institute for Spine Care (DISC) wants to help Valley residents address back, neck issues through awake spine surgery

As the weather begins to change, those with back issues can no longer rely on the dry heat to aid their backs. That's where DISC comes in.

J&J suspends COVID-19 vaccine sales forecast